These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 13873272)

  • 1. Letter to the editor on "the effect of 6-mercaptopurine riboside in 20 cases of childhood leukemia previously treated with purine antimetabolites.
    BROCKMAN RW
    Cancer Chemother Rep; 1962 May; 18():137-8. PubMed ID: 13873272
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of 6-mercaptopurine riboside in 20 cases of childhood leukemia previously treated with purine antimetabolites.
    PIERCE M; HALL J; OZOA N
    Cancer Chemother Rep; 1961 Oct; 14():121-8. PubMed ID: 14486464
    [No Abstract]   [Full Text] [Related]  

  • 3. Anticancer activity of purine antagonists and their ribosides. I. Comparative studies with 6-mercaptopurine and 6-mercaptopurine riboside.
    SKIPPER HE; THOMSON JR; HUTCHISON DJ; SCHABEL FM; JOHNSON JJ
    Proc Soc Exp Biol Med; 1957 May; 95(1):135-8. PubMed ID: 13432013
    [No Abstract]   [Full Text] [Related]  

  • 4. EFFECT OF 6-MERCAPTOPURINE RIBOSIDE (NSC-4911) IN 41 ADULT PATIENTS WITH ACUTE LEUKEMIA.
    WHITTINGTON RM; RIVERS SL; PATNO ME
    Cancer Chemother Rep; 1964 Jan; 34():47-50. PubMed ID: 14116218
    [No Abstract]   [Full Text] [Related]  

  • 5. The inhibition of polynucleotide phosphorylase by 6-mercaptopurine riboside 5'-diphosphate.
    CARBON JA
    Biochem Biophys Res Commun; 1962 May; 7():366-9. PubMed ID: 13876456
    [No Abstract]   [Full Text] [Related]  

  • 6. [THE PRESENT THERAPY OF ACUTE LEUKOSES IN CHILDHOOD--OUR EXPERIENCE].
    PANOFF A
    Monatsschr Kinderheilkd (1902); 1965 Jan; 113():21-5. PubMed ID: 14262903
    [No Abstract]   [Full Text] [Related]  

  • 7. Identification of 6-mercaptopurine riboside in patients receiving 6-mercaptopurine as a prolonged intravenous infusion.
    Zimm S; Grygiel JJ; Strong JM; Monks TJ; Poplack DG
    Biochem Pharmacol; 1984 Dec; 33(24):4089-92. PubMed ID: 6594999
    [No Abstract]   [Full Text] [Related]  

  • 8. Physical properties of pyrimidine and purine antimetabolites. I. The effects of salts and temperature on the solubility of 5-fluorouracil, 1-(2-tetrahydrofuryl)-5-fluorouracil, 6-mercaptopurine, and thrioinosine.
    Arakawa Y; Nakano M; Juni K; Arita T
    Chem Pharm Bull (Tokyo); 1976 Jul; 24(7):1654-7. PubMed ID: 975426
    [No Abstract]   [Full Text] [Related]  

  • 9. The stability of 6-mercaptopurine riboside in neutral and basic medium.
    Jelińska A; Magdziarz M
    Acta Pol Pharm; 2000; 57(6):407-9. PubMed ID: 11243244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. THE USE OF CHEMOTHERAPEUTIC AGENTS IN THE TREATMENT OF CHILDHOOD CANCER.
    DARBY CP
    J S C Med Assoc; 1964 Apr; 60():97-100. PubMed ID: 14138401
    [No Abstract]   [Full Text] [Related]  

  • 11. Adsorption of 6-mercaptopurine and 6-mercaptopurine-ribosideon silver colloid: a pH-dependent surface-enhanced Raman spectroscopy and density functional theory study. II. 6-mercaptopurine-riboside.
    Szeghalmi AV; Leopold L; Pînzaru S; Chis V; Silaghi-Dumitrescu I; Schmitt M; Popp J; Kiefer W
    Biopolymers; 2005 Aug; 78(6):298-310. PubMed ID: 15832317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 6-MERCAPTOPURINE riboside.
    Cancer Chemother Rep; 1960 Feb; 6():58-9. PubMed ID: 13856987
    [No Abstract]   [Full Text] [Related]  

  • 13. The absorption of 6-mercaptopurine from 6-mercaptopurine riboside in rat small intestine: effect of phosphate.
    Pennington AM; Bronk JR
    Cancer Chemother Pharmacol; 1995; 36(2):136-42. PubMed ID: 7767950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of the rejection of renal homografts in dogs by purine analogues.
    CALNE RY
    Plast Reconstr Surg; 1961 Oct; 28():65-81. PubMed ID: 13875840
    [No Abstract]   [Full Text] [Related]  

  • 15. [MORPHOLOGY OF ACUTE LEUKEMIAS IN CHILDREN AND ITS RELATION TO MODERN METHODS OF TREATMENT].
    DERGACHEV IS; POTAPOVA IN
    Pediatriia; 1963 Oct; 42():46-54. PubMed ID: 14122893
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of levamisole administration on treatment with 6-mercaptopurine riboside of mice bearing L1210 leukemia cells.
    Miura T; Nogiwa E; Kurashige S; Maekawa T
    Cancer Res; 1980 Dec; 40(12):4813-6. PubMed ID: 7438114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the effectiveness of standard dose 6-mercaptopurine, combination 6-mercaptopurine and DON, and high-loading 6-mercaptopurine therapies in the treatment of acute leukemia in children: results of cooperative study.
    SULLIVAN MP; BEATTY EC; HYMAN CP; MURPHY ML; PHERCE MI; SEVERO NC
    Cancer Chemother Rep; 1962 Feb; 16():161-4. PubMed ID: 13918322
    [No Abstract]   [Full Text] [Related]  

  • 18. The clinical and hematological response of previously treated leukemic subjects to the antimetabolite 6-mercaptopurine.
    WILSON SJ
    Ann N Y Acad Sci; 1954 Dec; 60(2):499-507. PubMed ID: 14350562
    [No Abstract]   [Full Text] [Related]  

  • 19. A comparison of red blood cell thiopurine metabolites in children with acute lymphoblastic leukemia who received oral mercaptopurine twice daily or once daily: a Pediatric Oncology Group study (now The Children's Oncology Group).
    Bell BA; Brockway GN; Shuster JJ; Erdmann G; Sterikoff S; Bostrom B; Camitta BM;
    Pediatr Blood Cancer; 2004 Aug; 43(2):105-9. PubMed ID: 15236274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of prior administration of aminophylline, caffeine, or propranolol on the antitumor activity of 6-mercaptopurine or 6-mercaptopurine riboside.
    Sasaki K; Furusawa S; Takayanagi G
    Chem Pharm Bull (Tokyo); 1981 Jan; 29(1):276-9. PubMed ID: 7196294
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.